Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1995Journal of Medicinal Chemistry

erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRodney C. SchnurPfizer (United States)MCMichael L. CormanInstitute for Diabetes DiscoveryRGRandall J. GallaschunPfizer (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schnur et al. (1995) studied this question.

synapsesocial.com/papers/6a6fa28526a7f98052dc436dhttps://doi.org/10.1021/jm00019a011
View Full Paper
Ask AI
Bookmark
Share